Meiji Yasuda Life Insurance CO Edwards Lifesciences Corp Transaction History

Meiji Yasuda Life Insurance CO

$5.39 Billion
Q3 2024

A detailed history of Meiji Yasuda Life Insurance CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Meiji Yasuda Life Insurance CO holds 8,866 shares of EW stock, worth $643,582. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,866

Previous 15,666 43.41%

Holding current value

$643,582

Previous $1.45 Million 59.57%

% of portfolio

0.01%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$59.7 - $93.78 $405,960 - $637,704	-6,800 Reduced 43.41%	8,866 $585,000
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $362,700 - $477,800	5,000 Added 46.88%	15,666 $1.5 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $623,641 - $785,842	-10,106 Reduced 48.65%	10,666 $813,000
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $91,449 - $123,261	1,320 Added 6.79%	20,772 $1.44 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $654,943 - $758,884	8,045 Added 70.53%	19,452 $1.84 Million
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $26,213 - $29,832	353 Added 3.19%	11,407 $944,000
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $60,104 - $76,947	-880 Reduced 7.37%	11,054 $825,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $60,789 - $79,180	738 Added 6.59%	11,934 $986,000
Q2 2022 Aug 16, 2022	BUY	$86.5 - $128.27 $274,810 - $407,513	3,177 Added 39.62%	11,196 $1.07 Million
Q1 2022 May 17, 2022	SELL	$101.96 - $128.34 $11,623 - $14,630	-114 Reduced 1.4%	8,019 $944,000
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $251,139 - $308,535	2,361 Added 40.9%	8,133 $1.05 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $235,788 - $300,055	-3,289 Reduced 36.3%	5,772 $527,000
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $6,719 - $8,744	100 Added 1.12%	9,061 $723,000
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $343,743 - $459,699	5,974 Added 200.0%	8,961 $619,000
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $27,095 - $41,877	-517 Reduced 14.75%	2,987 $563,000
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $28,680 - $32,836	400 Added 12.89%	3,504 $817,000
Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $9,232 - $11,314	-150 Reduced 4.61%	3,104 $683,000
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $181,545 - $209,783	-3,257 Reduced 50.02%	3,254 $601,000
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $38,072 - $50,919	-795 Reduced 10.88%	6,511 $1.25 Million
Q2 2018 Aug 13, 2018	SELL	$42.45 - $51.3 $152,820 - $184,680	-3,600 Reduced 33.01%	7,306 $1.06 Million
Q4 2017 Feb 13, 2018	SELL	$33.79 - $39.39 $20,071 - $23,397	-594 Reduced 5.17%	10,906 $1.23 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $417,335 - $446,545	11,500	11,500 $1.26 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Life Insurance CO with notifications on news.

Account

Meiji Yasuda Life Insurance CO Edwards Lifesciences Corp Transaction History